Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors
DEKA Biosciences
DEKA Biosciences
Jazz Pharmaceuticals
Eli Lilly and Company
Processa Pharmaceuticals
Sumitomo Pharma America, Inc.
Amgen
AbbVie
Albert Einstein College of Medicine
Montefiore Medical Center
Lipomedix Pharmaceuticals Inc.
R-Pharm
Alliance for Clinical Trials in Oncology
SCRI Development Innovations, LLC
University of Utah
SCRI Development Innovations, LLC
Duke University
University of California, San Francisco
Pfizer
Agennix
NYU Langone Health
Adherex Technologies, Inc.
University of New Mexico